Pediatrix (MD) Raised Its Outlook Floor. Why Did Mizuho Downgrade?
Mizuho Downgrades Pediatrix Medical Group to Underperform from Neutral
Pediatrix Medical Group (MD) Stock Still Looks Like A Bargain Despite Its 227% Run
Pediatrix Medical Group (MD) Gains Buy Backing As Valuation Questions Linger
How Investors May Respond To Pediatrix Medical Group Stock After Earnings Estimate Upgrades
Mizuho Downgrades Pediatrix Medical Group to Underperform, Maintains Price Target to $28
What Makes Pediatrix Medical Group (MD) a Strong Momentum Stock: Buy Now?
Pediatrix Medical Group (MD) Upgraded to Buy: Here's What You Should Know
Pediatrix Medical Group Consensus Price Target Increased by 10.13% to $29.58
Pediatrix Medical Group (MD) Q3 Results Leave Margin Pressure In Focus
Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $31
What Pediatrix Medical Group (MD) Said on Its Q3 Earnings Call
Pediatrix (MD) Q3 2026 Earnings Call Transcript
Pediatrix Medical Group, Inc. (MD) Q3 2026 Earnings Call Transcript
Pediatrix Medical Group Reports Third Quarter Results
Pediatrix Medical Group (NYSE:MD) Q3 2026 Earnings: Adjusted EPS Beat Offset by Revenue Shortfall
Pediatrix Medical Group (NYSE:MD) beats Q3 2026 sales expectations
Pediatrix Medical Group: Q3 Earnings Snapshot
Pediatrix Medical Group Q3 2026 Earnings Call Transcript
Pediatrix Medical Group Q3 Adj. EPS $0.72 Beats $0.65 Estimate, Sales $501.374M Beat $498.144M Estimate
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.